Remission induction therapies and long-term outcomes in granulomatosis with polyangiitis and microscopic polyangiitis: real-world data from a European cohort.

According to induction therapy, the composite renal endpoint occurred in 20.7% upon CYC therapy and in 30.0% following RTX within five years after initial diagnosis, yet this difference did not reach statistical significance suggesting that the choice of remission induction therapy did not affect major renal outcomes (Table 3 ).

also in 111,027 other papers